Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enzhuo Yang

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|January 15, 2015
PPE57 induces activation of macrophages and drives Th1-type immune responses through TLR2Ying Xu, Enzhuo Yang, Qi Huang, et al.
Emerging Microbes & Infections|June 29, 2022
Adjunctive Zoledronate + IL-2 administrations enhance anti-tuberculosis Vγ2Vδ2 T-effector populations, and improve treatment outcome of multidrug-resistant tuberculosis<sup>1</sup>Hongbo Shen, Enzhuo Yang, Ming Guo, et al.
European Journal of Immunology|August 22, 2014
Th17-related cytokines contribute to recall-like expansion/effector function of HMBPP-specific Vγ2Vδ2 T cells after Mycobacterium tuberculosis infection or vaccinationHongbo Shen, Yunqi Wang, Crystal Y Chen, et al.
Immunology|April 30, 2014
Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in miceYing Xu, Enzhuo Yang, Jianguang Wang, et al.
The Journal of Infectious Diseases|October 30, 2016
Selective Destruction of Interleukin 23-Induced Expansion of a Major Antigen-Specific γδ T-Cell Subset in Patients With TuberculosisHongbo Shen, Jin Gu, Heping Xiao, et al.
Clinical Immunology (Orlando, Fla.)|July 27, 2024
CD137 expression and signal function drive pleiotropic γδ T-cell effector functions that inhibit intracellular M. tuberculosis growthXuejiao Ji, Guixian Huang, Ying Peng, et al.
Angewandte Chemie (International Ed. in English)|November 23, 2019
Macrophage-Targeted Isoniazid-Selenium Nanoparticles Promote Antimicrobial Immunity and Synergize Bactericidal Destruction of Tuberculosis BacilliJiang Pi, Ling Shen, Enzhuo Yang, et al.
Frontiers in Immunology|March 18, 2021
A CD4+CD161+ T-Cell Subset Present in Unexposed Humans, Not Tb Patients, Are Fast Acting Cells That Inhibit the Growth of Intracellular Mycobacteria Involving CD161 Pathway, Perforin, and IFN-γ/AutophagyRui Yang, Ying Peng, Jiang Pi, et al.
Emerging Microbes & Infections|December 13, 2018
Multidrug-resistant tuberculosis (MDR-TB) strain infection in macaques results in high bacilli burdens in airways, driving broad innate/adaptive immune responsesEnzhuo Yang, Rui Yang, Ming Guo, et al.
ACS Infectious Diseases|October 14, 2016
Cell-Based High-Throughput Screening Assay Identifies 2',2'-Difluoro-2'-deoxycytidine Gemcitabine as a Potential Antipoliovirus AgentZhuoran Zhang, Enzhuo Yang, Chunmiao Hu, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Molecular Medicine (Berlin, Germany)|January 15, 2015
PPE57 induces activation of macrophages and drives Th1-type immune responses through TLR2Ying Xu, Enzhuo Yang, Qi Huang, et al.
Emerging Microbes & Infections|June 29, 2022
Adjunctive Zoledronate + IL-2 administrations enhance anti-tuberculosis Vγ2Vδ2 T-effector populations, and improve treatment outcome of multidrug-resistant tuberculosis<sup>1</sup>Hongbo Shen, Enzhuo Yang, Ming Guo, et al.
European Journal of Immunology|August 22, 2014
Th17-related cytokines contribute to recall-like expansion/effector function of HMBPP-specific Vγ2Vδ2 T cells after Mycobacterium tuberculosis infection or vaccinationHongbo Shen, Yunqi Wang, Crystal Y Chen, et al.
Immunology|April 30, 2014
Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in miceYing Xu, Enzhuo Yang, Jianguang Wang, et al.
The Journal of Infectious Diseases|October 30, 2016
Selective Destruction of Interleukin 23-Induced Expansion of a Major Antigen-Specific γδ T-Cell Subset in Patients With TuberculosisHongbo Shen, Jin Gu, Heping Xiao, et al.
Clinical Immunology (Orlando, Fla.)|July 27, 2024
CD137 expression and signal function drive pleiotropic γδ T-cell effector functions that inhibit intracellular M. tuberculosis growthXuejiao Ji, Guixian Huang, Ying Peng, et al.
Angewandte Chemie (International Ed. in English)|November 23, 2019
Macrophage-Targeted Isoniazid-Selenium Nanoparticles Promote Antimicrobial Immunity and Synergize Bactericidal Destruction of Tuberculosis BacilliJiang Pi, Ling Shen, Enzhuo Yang, et al.
Frontiers in Immunology|March 18, 2021
A CD4+CD161+ T-Cell Subset Present in Unexposed Humans, Not Tb Patients, Are Fast Acting Cells That Inhibit the Growth of Intracellular Mycobacteria Involving CD161 Pathway, Perforin, and IFN-γ/AutophagyRui Yang, Ying Peng, Jiang Pi, et al.
Emerging Microbes & Infections|December 13, 2018
Multidrug-resistant tuberculosis (MDR-TB) strain infection in macaques results in high bacilli burdens in airways, driving broad innate/adaptive immune responsesEnzhuo Yang, Rui Yang, Ming Guo, et al.
ACS Infectious Diseases|October 14, 2016
Cell-Based High-Throughput Screening Assay Identifies 2',2'-Difluoro-2'-deoxycytidine Gemcitabine as a Potential Antipoliovirus AgentZhuoran Zhang, Enzhuo Yang, Chunmiao Hu, et al.
Pageof 3